With Orion still flying, NASA is nearing key decisions about Artemis III

NASA is deciding the initial orbit for Artemis III (LEO ~160–2,000 km vs HEO >36,000 km) after inserting an Earth-orbit mission ahead of planned lunar landings to de-risk Artemis IV. Artemis III would launch Orion (presumably four astronauts) on an SLS from Florida and rendezvous in orbit with one or both Human Landing Systems (SpaceX Starship upper stage and Blue Origin's Blue Moon). Opting for LEO could allow NASA to forgo using the Interim Cryogenic Propulsion Stage (ICPS) and reserve it for Artemis IV, whereas a HEO profile would require ICPS to push Orion to higher orbit.

Analysis

The program-level choice pending at NASA is effectively a binary operational commitment that will create multi-year path dependency across hardware inventory, launch manifest sequencing, and contractor staffing. Whichever profile is locked in will consume or conserve scarce expendable upper-stage capacity and test-article flight opportunities, moving revenue recognition and supplier hiring plans by quarters — not days — and forcing reorder of development milestones across the ecosystem.

Commercial launch providers and in-space logistics vendors will face asymmetric optionality: firms with high cadence, low-cost orbital operations gain leverage to sell recurring missions and propellant-handling services, while large primes retain captive, quasi-guaranteed institutional spend through integration and mission assurance. Expect investor preference to tilt toward companies where a single additional mission or stage drives hundreds of millions in near-term backlog and where unit economics improve materially with cadence.

Supply-chain second-order effects include reallocation of specialized engine test stands, cryogenic tooling, and qualified propulsion personnel; bottlenecks here produce outsized schedule risk that can cascade into multi-million-dollar change orders and political scrutiny. Program reversals are plausibly triggered by a major in-flight anomaly, a high-profile commercial demonstrator success, or a budgetary pivot, each capable of flipping supplier winners into losers within 6-18 months.

Near-term catalyst windows are clear: the formal program decision (weeks), subsequent NASA procurement notices (1-3 months), and commercial demonstrator milestones (3-12 months). Trading this requires pairing exposure to secured institutional cashflows against the binary technical outcomes of commercial systems — calibrate position sizes to a 30-60% probability of near-term schedule slips and a 12-24 month horizon for revenue realization.

Key Decisions for Investors

• Long LMT (Lockheed Martin), 6-18 months — rationale: locked-in integration and mission-assurance work provides steady, government-backed revenue if institutional missions proceed; target +12% upside, stop-loss -8% (size 2-4% portfolio).
• Buy AJRD (Aerojet Rocketdyne) 9–18 month call spread (buy 12-month ATM call, sell higher strike) — rationale: engine demand and upper-stage propulsion testing accelerate cash conversion with cadence; capped upside reduces headline volatility, risk/reward ~2:1 if program consumes additional stages.
• Long NOC (Northrop Grumman), 12 months — rationale: systems and stage hardware suppliers benefit from higher integration workload and contingency orders; target +10%, stop-loss -10%, allocate 1-3% portfolio.
• Pair trade (hedged): Long LMT + AJRD vs Short RKLB (Rocket Lab), 6-12 months — rationale: favor incumbents with institutional contracts over pure-play commercial launchers if manifest choice privileges heavy-lift and repeatable institutional ops; size net exposure conservatively, expect asymmetric payoff if commercial demonstrators fail to meet milestones.